Drugs / MucoMilk
last change Aug 2005 re-read 3 minutes ago

MucoMilk

Protein / enzyme biologic

Developed for
Clostridium difficile colitis
Investigated by
MucoVax, BV, the Netherlands · University of Pittsburgh

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT00177775 Apr → Aug 2005 Clostridium difficile colitis University of Pittsburgh Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MucoMilk ClinicalTrials.gov intervention name — accepted as the source's own label NCT00177775 ↗
Modality Protein / enzyme biologic “a polyclonal-antibody enriched Whey Protein Concentrate 40% (WPC-40) made of milk of immunized cows” NCT00177775 ↗